XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.4
Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2021
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended December 31, 

    

Six Months Ended December 31, 

    

2020

    

2021

    

2020

    

2021

Cost of goods sold

$

194

$

205

$

373

$

411

Selling, general and administrative

5,384

6,642

 

11,168

13,410

Research and development

135

127

 

280

267

Stock-based compensation expense

$

5,713

$

6,974

$

11,821

$

14,088

Summary of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2021

 

255,220

 

$

50.24

 

Granted

 

22,954

96.38

Exercised

 

(164,612)

34.61

Expired or forfeited

 

(834)

71.83

Outstanding at December 31, 2021

 

112,728

82.30

6.7 years

$

1,408

Exercisable at December 31, 2021

68,063

75.13

 

5.0 years

1,265

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2021

 

435,925

$

84.16

Granted

 

333,897

90.44

Vested

 

(329,072)

82.49

Forfeited

 

(3,233)

82.53

Nonvested at December 31, 2021

 

437,517

$

90.22